These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 34655851)
1. Recent advances in studies of 15-PGDH as a key enzyme for the degradation of prostaglandins. Sun CC; Zhou ZQ; Yang D; Chen ZL; Zhou YY; Wen W; Feng C; Zheng L; Peng XY; Tang CF Int Immunopharmacol; 2021 Dec; 101(Pt B):108176. PubMed ID: 34655851 [TBL] [Abstract][Full Text] [Related]
2. Recent advances in studies of SLCO2A1 as a key regulator of the delivery of prostaglandins to their sites of action. Nakanishi T; Nakamura Y; Umeno J Pharmacol Ther; 2021 Jul; 223():107803. PubMed ID: 33465398 [TBL] [Abstract][Full Text] [Related]
3. Roles of Organic Anion Transporting Polypeptide 2A1 (OATP2A1/SLCO2A1) in Regulating the Pathophysiological Actions of Prostaglandins. Nakanishi T; Tamai I AAPS J; 2017 Dec; 20(1):13. PubMed ID: 29204966 [TBL] [Abstract][Full Text] [Related]
4. Antinidatory effect of luteal phase administration of mifepristone (RU486) is associated with changes in endometrial prostaglandins during the implantation window. Nayak NR; Sengupta J; Ghosh D Contraception; 1998 Aug; 58(2):111-7. PubMed ID: 9773266 [TBL] [Abstract][Full Text] [Related]
5. NAD+-dependent 15-hydroxyprostaglandin dehydrogenase regulates levels of bioactive lipids in non-small cell lung cancer. Hughes D; Otani T; Yang P; Newman RA; Yantiss RK; Altorki NK; Port JL; Yan M; Markowitz SD; Mazumdar M; Tai HH; Subbaramaiah K; Dannenberg AJ Cancer Prev Res (Phila); 2008 Sep; 1(4):241-9. PubMed ID: 19138967 [TBL] [Abstract][Full Text] [Related]
6. TISSUE REGENERATION. Inhibition of the prostaglandin-degrading enzyme 15-PGDH potentiates tissue regeneration. Zhang Y; Desai A; Yang SY; Bae KB; Antczak MI; Fink SP; Tiwari S; Willis JE; Williams NS; Dawson DM; Wald D; Chen WD; Wang Z; Kasturi L; Larusch GA; He L; Cominelli F; Di Martino L; Djuric Z; Milne GL; Chance M; Sanabria J; Dealwis C; Mikkola D; Naidoo J; Wei S; Tai HH; Gerson SL; Ready JM; Posner B; Willson JK; Markowitz SD Science; 2015 Jun; 348(6240):aaa2340. PubMed ID: 26068857 [TBL] [Abstract][Full Text] [Related]
7. 15-hydroxyprostaglandin dehydrogenase-derived 15-keto-prostaglandin E2 inhibits cholangiocarcinoma cell growth through interaction with peroxisome proliferator-activated receptor-γ, SMAD2/3, and TAP63 proteins. Lu D; Han C; Wu T J Biol Chem; 2013 Jul; 288(27):19484-502. PubMed ID: 23687300 [TBL] [Abstract][Full Text] [Related]
8. Prostaglandin catabolic enzymes as tumor suppressors. Tai HH Cancer Metastasis Rev; 2011 Dec; 30(3-4):409-17. PubMed ID: 22020925 [TBL] [Abstract][Full Text] [Related]
9. C-Terminal region of human NAD+-dependent 15-hydroxyprostaglandin dehydrogenase is involved in the interaction with prostaglandin substrates. Zhou H; Yan F; Tai HH Eur J Biochem; 2001 Jun; 268(12):3368-74. PubMed ID: 11422365 [TBL] [Abstract][Full Text] [Related]
10. UV radiation inhibits 15-hydroxyprostaglandin dehydrogenase levels in human skin: evidence of transcriptional suppression. Judson BL; Miyaki A; Kekatpure VD; Du B; Gilleaudeau P; Sullivan-Whalen M; Mohebati A; Nair S; Boyle JO; Granstein RD; Subbaramaiah K; Krueger JG; Dannenberg AJ Cancer Prev Res (Phila); 2010 Sep; 3(9):1104-11. PubMed ID: 20643784 [TBL] [Abstract][Full Text] [Related]
11. Expression of NAD+ dependent 15-hydroxyprostaglandin dehydrogenase and protection of prostaglandins in human hair follicle. Michelet JF; Colombe L; Gautier B; Gaillard O; Benech F; Pereira R; Boulle C; Dalko-Csiba M; Rozot R; Neuwels M; Bernard BA Exp Dermatol; 2008 Oct; 17(10):821-8. PubMed ID: 18328086 [TBL] [Abstract][Full Text] [Related]
12. Inhibitors of 15-Prostaglandin Dehydrogenase To Potentiate Tissue Repair. Antczak MI; Zhang Y; Wang C; Doran J; Naidoo J; Voruganti S; Williams NS; Markowitz SD; Ready JM J Med Chem; 2017 May; 60(9):3979-4001. PubMed ID: 28398755 [TBL] [Abstract][Full Text] [Related]
13. Multiple drug resistance-associated protein 4 (MRP4), prostaglandin transporter (PGT), and 15-hydroxyprostaglandin dehydrogenase (15-PGDH) as determinants of PGE2 levels in cancer. Kochel TJ; Fulton AM Prostaglandins Other Lipid Mediat; 2015; 116-117():99-103. PubMed ID: 25433169 [TBL] [Abstract][Full Text] [Related]
14. NAD+-linked 15-hydroxyprostaglandin dehydrogenase: structure and biological functions. Tai HH; Cho H; Tong M; Ding Y Curr Pharm Des; 2006; 12(8):955-62. PubMed ID: 16533162 [TBL] [Abstract][Full Text] [Related]
15. 15-hydroxyprostaglandin dehydrogenase (15-PGDH) prevents lipopolysaccharide (LPS)-induced acute liver injury. Yao L; Chen W; Song K; Han C; Gandhi CR; Lim K; Wu T PLoS One; 2017; 12(4):e0176106. PubMed ID: 28423012 [TBL] [Abstract][Full Text] [Related]
16. [Study on PGDH activity in human term placenta--relationship between PGDH activities and perinatal factors]. Tsuruta K; Mori N Nihon Sanka Fujinka Gakkai Zasshi; 1985 Oct; 37(10):2023-30. PubMed ID: 3878384 [TBL] [Abstract][Full Text] [Related]
17. [Role of prostaglandins in colon cancer]. Myung SJ; Kim IH Korean J Gastroenterol; 2008 May; 51(5):274-9. PubMed ID: 18516010 [TBL] [Abstract][Full Text] [Related]
18. Expression of 15-Hydroxyprostaglandin Dehydrogenase in Human Chorion Is Associated with Peroxisome Proliferator-Activated Receptor Isoform Expression in Term Labor. He P; Li Y; Ding X; Sun Q; Huang Y; Gu H; Ni X Am J Pathol; 2015 Jul; 185(7):1981-90. PubMed ID: 26093984 [TBL] [Abstract][Full Text] [Related]
19. 15-Hydroxyprostaglandin dehydrogenase as a novel molecular target for cancer chemoprevention and therapy. Na HK; Park JM; Lee HG; Lee HN; Myung SJ; Surh YJ Biochem Pharmacol; 2011 Nov; 82(10):1352-60. PubMed ID: 21856294 [TBL] [Abstract][Full Text] [Related]
20. 15-PGDH regulates hematopoietic and gastrointestinal fitness during aging. Ho WJ; Smith JNP; Park YS; Hadiono M; Christo K; Jogasuria A; Zhang Y; Broncano AV; Kasturi L; Dawson DM; Gerson SL; Markowitz SD; Desai AB PLoS One; 2022; 17(5):e0268787. PubMed ID: 35587945 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]